Publikationen

Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbejin, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Grifoni, A., Sette, A., van de Vijver, D., Koopmans, M. P. G., et al. (2023). Imvanex vaccination induces immune responses against monkeypox virus and likely contributes to the prevention of future outbreaks. In 32nd Annual Meeting of the Society of Virology: abstracts (P 303).
Details anzeigen

Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbeijn, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Koopmans, M. P. G., Haagmans, B. L., GeurtsvanKessel, C. H., & de Vries, R. D. (2023). Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature Medicine, 29(1), 270–278. https://doi.org/10.1038/s41591-022-02090-w
Details anzeigen

de Vries, R. D., Hoschler, K., & Rimmelzwaan, G. (2023). ADCC: an underappreciated correlate of cross-protection against influenza? Frontiers in Immunology, 14, Article 1130725. https://doi.org/10.3389/fimmu.2023.1130725
Details anzeigen

Jansen, J. M. (2022). T cell-mediated immunity to influenza virus and SARS-CoV-2: effect of host adaptation and aging. https://nbn-resolving.org/urn:nbn:de:gbv:95-118059
Details anzeigen

Jonczyk, R., Stanislawski, N., Seiler, L. K., Ahani, S., Bueltemeier, A., Stahl, F., Beutel, S., Blume, H., Hauß, C., Melk, A., Paulsen, M., Stiesch, M., Winkel, A., Pott, P.-C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Blume, C. (2022). Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity. Journal of Clinical Virology, 157, Article 105322. https://doi.org/10.1016/j.jcv.2022.105322
Details anzeigen

Jonczyk, R., Stanislawski, N., Seiler, L. K., Blume, H., Heiden, S., Lucas, H., Sarikouch, S., Pott, P.-C., Stiesch, M., Hauß, C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G., Osterhaus, A., & Blume, C. (2022). Combined prospective seroconversion and PCR data of selected cohorts indicate a high rate of subclinical SARS-CoV-2 infections: an open observational study in Lower Saxony, Germany. Microbiology Spectrum, 10(1), Article e0151221. https://doi.org/10.1128/spectrum.01512-21
Details anzeigen

Lombardo, M. S., de le Roi, M., Postel, A., King, J., Kaiser, F. K., Kennedy, J., Reineking, W., Harder, T., Pohlmann, A., Gerlach, T., Rimmelzwaan, G., Rohner, S., Striewe, L. C., Gross, S., Schick, L. A., Klink, J. C., Kramer, K., Osterhaus, A. D. M. E., Beer, M., et al. (2022). Infektion des zentralen Nervensystems mit aviärem Influenza-A-Virus des Subtyps H5N8 in Seehunden (Phoca vitulina) an der deutschen Nordseeküste. In Tierärztliche Praxis / G (P12). Thieme. https://doi.org/10.1055/s-0042-1749978
Details anzeigen

Lombardo, M. S., de le Roi, M., Postel, A., King, J., Kaiser, F. K., Kennedy, J., Reineking, W., Harder, T., Pohlmann, A., Gerlach, T., Rimmelzwaan, G., Rohner, S., Striewe, L. C., Groß, S., Schick, L. A., Klink, J. C., Kramer, K., Osterhaus, A., Beer, M., et al. (2022). Infektion des zentralen Nervensystems mit aviärem Influenza-A-Virus des Subtyps H5N8 in Seehunden (Phoca vitulina) an der deutschen Nordseeküste. In A. Beineke (ed.), 65. Jahrestagung und 27. Schnittseminar der DVG-Fachgruppe Pathologie (Poster 24). Verlag der DVG-Service.
Details anzeigen

Meineke, R. (2022). Inhibition of Host Kinase Activity: Effects on Influenza A Virus Infection and Host Cell Signaling. https://nbn-resolving.org/urn:nbn:de:gbv:95-117384
Details anzeigen

Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2022). FDA-approved inhibitors of RTK/Raf signaling potently impair multiple steps of in vitro and ex vivo influenza A virus infections. Viruses, 14(9), Article 2058. https://doi.org/10.3390/v14092058
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Volk, H. A., Osterhaus, A., von Köckritz-Blickwede, M., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. In 32nd Annual Meeting of the Society of Virology: abstracts (P 267).
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Fathi, A., Addo, M. M., Volk, H. A., Osterhaus, A., Köckritz-Blickwede, M. v., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods, 317, 114733. https://doi.org/10.1016/j.jviromet.2023.114733
Details anzeigen

Schweitzer, F., Schröder, L.-J., Gudi, V., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Chittappen Kandiyil, P. (2023). In vitro CNS model to study neuroinvasion and pathogenesis of tick-borne encephalitis virus. In 16th Graduate School Day: 24/25 November 2023 : abstract book (ZSN P 13). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
Details anzeigen

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
Details anzeigen

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20), Article 12492. https://doi.org/10.3390/ijms232012492
Details anzeigen

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen

Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
Details anzeigen

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen